COMPANY OVERVIEW

Airway Therapeutics is a spin-out of Cincinnati Children’s Hospital Medical Center (CCHMC). Their goal is to bring innovation and expertise in protein therapeutics development for applications in the lung and pediatrics disciplines.

---

LOCATION

Cincinnati,, OH, USA

Marietta, GA, USA

---

THERAPEUTIC AREAS

Pediatric

Respiratory Disease

---

WEBSITE

https://www.airwaytherapeutics.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Oct 3, 2022

Airway Therapeutics Opens International Clinical Trial Sites and Treats First Patient in Spain in Phase 1b Study of Zelpultide Alfa (AT-100) in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) USA - English USA - español USA - Deutsch USA - Français USA - English

Apr 1, 2022

Airway Therapeutics annonce la première dose administrée au patient dans l'essai de phase 1b de l'AT-100 chez les nourrissons prématurés à risque de dysplasie bronchopulmonaire (DBP) Israel - Français USA - English Israel - English USA - español USA - Deutsch Latin America - español Brazil - Português

Apr 1, 2022

Airway Therapeutics gibt die Verabreichung von AT-100 beim ersten Patienten in der Phase Ib-Studie bei Frühgeborenen mit Risiko für bronchopulmonale Dysplasie (BPD) bekannt Israel - Deutsch USA - English Israel - English USA - español Latin America - español Brazil - Português

Mar 31, 2022

Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) USA - English Israel - English USA - español USA - Deutsch Latin America - español Brazil - Português

Mar 31, 2022

Airway Therapeutics anuncia primeiro paciente medicado no estudo de fase 1b da AT-100 em bebês prematuros em risco de displasia broncopulmonar (DBP) Brazil - Português USA - English Israel - English USA - español USA - Deutsch Latin America - español

For More Press Releases

---